These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24765821)

  • 21. [The seventeenth report on Survey of the Adverse Reaction to Radiopharmaceuticals (the 20th survey in 1994). Subcommittee of Safety Issue for the Radiopharmaceuticals Medical and Pharmaceutical Committee. Japan Radioisotope Association].
    Kaku Igaku; 1996 Jun; 33(6):675-86. PubMed ID: 8741514
    [No Abstract]   [Full Text] [Related]  

  • 22. Full report on a survey of adverse reactions to radiopharmaceuticals from 1975 to 2017 in Japan.
    Matsuda H; Uehara T; Okazawa H; Mizumura S; Yokoyama K; Yoshimura M;
    Ann Nucl Med; 2020 Apr; 34(4):299-304. PubMed ID: 31989466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of adverse reactions in nuclear medicine. Pharmacopeia Committee of the Society of Nuclear Medicine.
    Silberstein EB; Ryan J
    J Nucl Med; 1996 Jan; 37(1):185-92. PubMed ID: 8543992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse reactions to radiopharmaceuticals in France: analysis of the national pharmacovigilance database.
    Laroche ML; Quelven I; Mazère J; Merle L
    Ann Pharmacother; 2015 Jan; 49(1):39-47. PubMed ID: 25366341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency of adverse reactions to radiopharmaceuticals in Europe.
    Hesslewood SR; Keeling DH
    Eur J Nucl Med; 1997 Sep; 24(9):1179-82. PubMed ID: 9283115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The fourteenth report on survey of the adverse reaction to radiopharmaceuticals (the 17th survey in 1991). Subcommittee of Safety Issue for the Radiopharmaceuticals Medical and Pharmaceutical Committee Japan Radioisotope Association].
    Kaku Igaku; 1993 May; 30(5):575-81. PubMed ID: 8336418
    [No Abstract]   [Full Text] [Related]  

  • 27. [The Sixteenth Report on Survey of the Adverse Reactions to Radiopharmaceuticals (the 19th survey in 1993)].
    Kaku Igaku; 1995 Jun; 32(6):605-13. PubMed ID: 7674572
    [No Abstract]   [Full Text] [Related]  

  • 28. [The tenth report on survey of the adverse reaction to radiopharmaceuticals (the 13th survey in 1987). Subcommittee of Safety Issue for the Radiopharmaceuticals Medical and Pharmaceutical Committee Japan Radioisotope Association].
    Kaku Igaku; 1989 Apr; 26(4):565-72. PubMed ID: 2770047
    [No Abstract]   [Full Text] [Related]  

  • 29. [The fifth report on the survey of adverse reactions to radiopharmaceuticals (the 8th survey in 1982)].
    Kaku Igaku; 1984 Mar; 21(3):283-7. PubMed ID: 6590905
    [No Abstract]   [Full Text] [Related]  

  • 30. [Survey on adverse reactions to radiopharmaceuticals: Report No. 3 (the 6th survey in 1980)].
    Kaku Igaku; 1982 Aug; 19(7):1099-105. PubMed ID: 6757501
    [No Abstract]   [Full Text] [Related]  

  • 31. European system for reporting adverse reactions to and defects in radiopharmaceuticals: annual report 2000.
    Hesslewood SE
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):BP13-9. PubMed ID: 11976816
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of Radiopharmaceutical Adverse Reaction Reports to the British Nuclear Medicine Society from 2007 to 2016.
    Kennedy-Dixon TG; Gossell-Williams M; Cooper M; Trabelsi M; Vinjamuri S
    J Nucl Med; 2017 Dec; 58(12):2010-2012. PubMed ID: 28522742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The eleventh report on Survey of the Adverse Reaction to Radiopharmaceuticals (the 14th survey in 1988). Subcommittee of Safety Issue for the Radiopharmaceuticals Medical and Pharmaceutical Committee Japan Radioisotope Association].
    Kaku Igaku; 1991 Mar; 28(3):323-8. PubMed ID: 2046189
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevalence of adverse reactions to positron emitting radiopharmaceuticals in nuclear medicine. Pharmacopeia Committee of the Society of Nuclear Medicine.
    Silberstein EB
    J Nucl Med; 1998 Dec; 39(12):2190-2. PubMed ID: 9867168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The second report on survey of the adverse reaction to radiopharmaceuticals in Japan (author's transl)].
    Kaku Igaku; 1981 Apr; 18(3):415-9. PubMed ID: 7277886
    [No Abstract]   [Full Text] [Related]  

  • 36. Adverse Reactions to Radiopharmaceuticals: A Survey Based on Clinical Cases Using Criteria of Systematic Review.
    Pinto SR; Santos LFC; Dos Reis SRR; Bastos MK; Gomes VDS; Vieira TO; Santos-Oliveira R
    Ther Innov Regul Sci; 2018 Jan; 52(1):109-113. PubMed ID: 29714615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Survey of the adverse reaction to radiopharmaceuticals in Japan (author's transl)].
    Kaku Igaku; 1979 May; 16(3):511-6. PubMed ID: 480724
    [No Abstract]   [Full Text] [Related]  

  • 38. [The thirteenth report on survey of the adverse reaction to radiopharmaceuticals (the 16th survey in 1990). Subcommittee of Safety Issue for the Radiopharmaceuticals Medical and Pharmaceutical Committee Japan Radioisotope Association].
    Kaku Igaku; 1992 Mar; 29(3):399-405. PubMed ID: 1583811
    [No Abstract]   [Full Text] [Related]  

  • 39. European system for reporting adverse reactions to and defects in radiopharmaceuticals: annual report 1995.
    Eur J Nucl Med; 1996 Dec; 23(12):BP27-31. PubMed ID: 9005137
    [No Abstract]   [Full Text] [Related]  

  • 40. Pitfalls with radiopharmaceuticals.
    Santos-Oliveira R; Machado M
    Am J Med Sci; 2011 Jul; 342(1):50-3. PubMed ID: 21642816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.